Oxygen activatable formulations for disinfection or sterilization
Abstract
Methods and compositions are disclosed for producing air-activated, i.e., oxygen (O2) activated, disinfectant-sterilent solutions. Solutions containing a haloperoxidase (i.e., a halide:hydrogen peroxide (H2O2) oxidoreductase, such as myeloperoxidase, eosinophil peroxidase or lactoperoxidase) plus a halide or combination of halides (i.e., chloride, bromide and/or iodide), an oxidase (i.e., a substrate:O2 oxidoreductase) capable of generating H2O2, and a substrate specific for that oxidase, are separately prepared under aerobic conditions, but all of the component solutions are made anaerobic prior to final combination and mixing. The anaerobic formulations are dispensed into containers capable of maintaining the anaerobic condition (e.g., pressurized canisters). Dispensing the solution at the time of use exposes the formulation to air (i.e., O2) which activates its disinfectant-sterilent properties. O2 is the rate limiting component for oxidase generation of H2O2. Under aerobic conditions the oxidase catalyzes the oxidation of its substrate and the reduction of O2 to generate H2O2. In turn, H2O2 serves as substrate for haloperoxidase which catalyzes the oxidation of halide to hypohalous acid. Hypohalous acid reacts with an additional H2O2 to generate singlet molecular oxygen (1O2). Hypohalous acid (e.g., hypochlorous acid) and especially 1O2 are potent microbicidal agents. Both haloperoxidase generation of hypohalous acid and its reactive consumption to yield 1O2 are dependent on the availability of H2O2. A high rate of H2O2 generation does not result in the accumulation of hypohalous acid, but instead results in a high rate of 1O2 production. The microbicidal capacity and toxicity of 1O2 are limited by the half-life of this metastable electronically excited reactant, and as such, disinfectant-sterilent activity is temporally defined by and confined to the dynamics of oxidant generation. The disinfectant-sterilent activity of formulation requires air exposure and is dependent on the presence of the halide-haloperoxidase combination employed, the activity of the oxidase present, the availability of oxidase-specific substrate and the availability of O2.
Term
Term ended
Projected expiry passed 9 May 2016, 10.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
84 members in 13 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 45752495 | United States of America | A | |
| 9606687 | United States of America | W |
Members84
| Document | Office | Kind | |
|---|---|---|---|
| CA2061601A1 | Canada | A1 | |
| EP0500387A2 | European Patent Office (EPO) | A2 | |
| IE920514A1 | Ireland | A1 | |
| WO9214484A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1536492A | Australia | A | |
| EP0500387A3 | European Patent Office (EPO) | A3 | |
| IL100997D0 | Israel | D0 | |
| KR930703012A | Republic of Korea | A | |
| JPH06505482A | Japan | A | |
| CA2158576A1 | Canada | A1 | |
| WO9423742A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6697194A | Australia | A | |
| CA2167525A1 | Canada | A1 | |
| WO9504135A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US5389369A | United States of America | A | |
| AU7477294A | Australia | A | |
| US5451402A | United States of America | A | |
| AU663869B2 | Australia | B2 | |
| EP0693934A1 | European Patent Office (EPO) | A1 | |
| KR960701656A | Republic of Korea | A | |
| US5510104A | United States of America | A | |
| EP0713527A1 | European Patent Office (EPO) | A1 | |
| CN1128044A | China | A | |
| IL100997A | Israel | A | |
| US5565197A | United States of America | A | |
| JPH08511001A | Japan | A | |
| CA2222964A1 | Canada | A1 | |
| WO9638548A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5740196A | Australia | A | |
| JPH09503752A | Japan | A | |
| AU679777B2 | Australia | B2 | |
| AU684505B2 | Australia | B2 | |
| EP0713527A4 | European Patent Office (EPO) | A4 | |
| US5718896A | United States of America | A | |
| EP0832198A1 | European Patent Office (EPO) | A1 | |
| US5756090A | United States of America | A | |
| KR19990022188A | Republic of Korea | A | |
| US5888505A | United States of America | A | |
| JPH11506444A | Japan | A | |
| EP0923939A1 | European Patent Office (EPO) | A1 | |
| EP0500387B1 | European Patent Office (EPO) | B1 | |
| AT181837T | Austria | T | |
| ATE181837T1 | Austria | T1 | |
| AU708557B2 | Australia | B2 | |
| DE69229512D1 | Germany | D1 | |
| US6033662A | United States of America | A | |
| DE69229512T2 | Germany | T2 | |
| IE20000984A1 | Ireland | A1 | |
| US6294168B1 | United States of America | B1 | |
| EP0713527B1 | European Patent Office (EPO) | B1 | |
| AT208563T | Austria | T | |
| ATE208563T1 | Austria | T1 | |
| KR100306968B1 | Republic of Korea | B1 | |
| DK0713527T3 | Denmark | T3 | |
| DE69429094D1 | Germany | D1 | |
| EP0832198A4 | European Patent Office (EPO) | A4 | |
| DE69429094T2 | Germany | T2 | |
| CN1081672C | China | C | |
| KR100325901B1 | Republic of Korea | B1 | |
| EP0693934B1 | European Patent Office (EPO) | B1 | |
| AT225667T | Austria | T | |
| ATE225667T1 | Austria | T1 | |
| DE69431519D1 | Germany | D1 | |
| US6503507B1 | United States of America | B1 | |
| DE69431519T2 | Germany | T2 | |
| CA2061601C | Canada | C | |
| EP0832198B1 | European Patent Office (EPO) | B1 | |
| AT246243T | Austria | T | |
| ATE246243T1This record | Austria | T1 | |
| DE69629296D1 | Germany | D1 | |
| DE69629296T2 | Germany | T2 | |
| JP2004300157A | Japan | A | |
| KR100449283B1 | Republic of Korea | B1 | |
| JP3723209B2 | Japan | B2 | |
| CA2167525C | Canada | C | |
| JP2007051153A | Japan | A | |
| EP0923939B1 | European Patent Office (EPO) | B1 | |
| AT365048T | Austria | T | |
| ATE365048T1 | Austria | T1 | |
| DE69233698D1 | Germany | D1 | |
| CA2158576C | Canada | C | |
| DE69233698T2 | Germany | T2 | |
| JP4063317B2 | Japan | B2 | |
| CA2222964C | Canada | C |
Numbers
- Application
- 96915689
Titles2
- English
- OXYGEN-ACTIVATIVE COMPOSITIONS FOR DISINFECTION OR STERILIZATION
- German
- SAUERSTOFFAKTIVIERBARE ZUSAMMENSETZUNGEN ZUR DESINFECTION ODER STERILISATION
Classification
- CPC, 22
- A61L2/186
- C12N9/0004
- A61L2/16
- A61L2/22
- A61L12/082
- A61L12/126
- A61L15/38
- A61L15/46
- A61L2202/122
- A61L2300/102
- A61L2300/106
- A61L2300/11
- A61L2300/254
- A61L2300/404
- C12N9/0065
- A61K38/00
- A61K45/06
- A61K31/198
- A61P27/02
- A61P31/04
- A61P43/00
- A61L2103/15
- IPC, 22
- A61K38 44
- A01N59 00
- A01N63 00
- A61K31 195
- A61K31 215
- A61K31 50
- A61K33 00
- A61K33 18
- A61K33 20
- A61K33 40
- A61K45 00
- A61L2 16
- A61L2 18
- A61L2 22
- A61L12 08
- A61L12 12
- A61L15 38
- A61L15 46
- A61P27 02
- A61P31 04
- A61P43 00
- C12N9 08